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Background: Intramuscular fat (IMF) content is positively correlated with aspects of pork palatability, including
flavour, juiciness and overall acceptability. The ratio of energy to protein in the finishing diet of growing pigs can
impact on IMF content with consequences for pork quality. The objective of this study was to compare gene
expression profiles of Musculus semimembranosus (SM) of animals divergent for IMF as a consequence of protein
dietary restriction in an isocaloric diet. The animal model was derived through the imposition of low or high
protein diets during the finisher stage in Duroc gilts. RNA was extracted from post mortem SM tissue, processed
and hybridised to Affymetrix porcine GeneChip® arrays.
Results: IMF content of SM muscle was increased on the low protein diet (3.60 ± 0.38% versus 1.92 ± 0.35%).
Backfat depth was also greater in animals on the low protein diet, and average daily gain and feed conversion ratio
were lower, but muscle depth, protein content and moisture content were not affected. A total of 542 annotated
genes were differentially expressed (DE) between animals on low and high protein diets, with 351 down-regulated
and 191 up-regulated on the low protein diet. Transcript differences were validated for a subset of DE genes by
qPCR. Alterations in functions related to cell cycle, muscle growth, extracellular matrix organisation, collagen
development, lipogenesis and lipolysis, were observed. Expression of adipokines including LEP, TNFα and HIF1α were
increased and the hypoxic stress response was induced. Many of the identified transcriptomic responses have also
been observed in genetic and fetal programming models of differential IMF accumulation, indicating they may be
robust biological indicators of IMF content.
Conclusion: An extensive perturbation of overall energy metabolism in muscle occurs in response to protein
restriction. A low protein diet can modulate IMF content of the SM by altering gene pathways involved in lipid
biosynthesis and degradation; however this nutritional challenge negatively impacts protein synthesis pathways,
with potential consequences for growth.Background
Intra-muscular fat (IMF), also known as marbling fat, is
an adipocyte depot located within perimysial connective
tissues alongside myofibres [1]. Intramuscular fat is a
late-developing depot and intramuscular adipocytes have
been shown to be metabolically distinct from adipocytes
in other depots, such as subcutaneous fat, as reviewed
by Hausman et al. [1]. IMF is very important in defining* Correspondence: ruth.hamill@teagasc.ie
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reproduction in any medium, provided the orpork quality from a sensory perspective, since it is
positively correlated with flavour, juiciness, tenderness/
firmness and overall acceptability of pork [2-4]. Further-
more, IMF also has an important influence on the sen-
sory characteristics of dry-cured ham, an economically
significant processed product [5]. Some authors propose
a minimum threshold of 1.5% IMF for acceptable eating
quality in fresh pork [3], while other studies suggest that
levels of 2 to 3% IMF are required to ensure desirable
eating quality [6]. Currently, IMF levels in the majority of
modern commercial breeds are typically less than 1.5%
[7,8]. While this is largely due to genetic selection forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Animal performance, carcass and meat quality on
dietary treatments
Traits LP diet (n = 5) HP diet (n = 6) P-value
Mean ± S.E. Mean ± S.E.
Initial weight (kg) 45.75 ± 2.85 46.50 ± 1.89 0.83
Feed intake (g/day) 1758.5 ± 127.2 2013.1 ± 107.0 0.170
Feed conversion ratio 3.40 ± 0.10 2.41 ± 0.11 <0.001
Average daily gain (kg) 0.52 ± 0.03 0.83 ± 0.03 <0.001
Carcass weight (kg) 61.62 ± 11.08 71.56 ± 5.85 0.088
Fat depth ¾ rib (mm) 9.55 ± 2.21 6.79 ± 1.39 0.032
Loin depth (mm) 54.24 ± 10.58 59.76 ± 5.24 0.29
IMF (%) SM day 2 3.60 ± 0.38 1.92 ± 0.35 <0.001
Protein (%) SM day 2 21.26 ± 0.36 22.19 ± 0.33 0.45
Moisture (%) SM day 2 73.48 ± 0.41 74.11 ± 0.38 0.93
SM: M. semimembranosus muscle.
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quality traits including IMF are influenced by an inter-
action between genotype and environmental factors such
as level of nutrition [9-11]. An improved ability to ma-
nipulate IMF deposition could provide a basis to enhance
uniformity in desirable eating quality characteristics
in commercial production, but a more complete under-
standing of porcine muscle biology in relation to intramus-
cular fat deposition, in particular in the more commercially
relevant muscles, is first required.
Dietary protein restriction during the growth/finisher
phase in pigs, relative to overall energy content in the
diet, is a nutritional strategy which has several profound
effects on the pig, including reduced lean deposition, in-
creased fat deposition throughout the carcass, and in
particular, in the economically significant depot of IMF
[12-15]. For example, feeding pigs a 15% reduced lysine:
energy diet significantly increased IMF levels and fur-
thermore improved juiciness, tenderness and overall ac-
ceptability scores by sensory panellists [12,16]. While
extreme restriction strategies have also been shown to
impair growth, limiting their relevance to the commer-
cial setting, the generation of muscle displaying diver-
gent IMF through such a dietary intervention provides a
valuable resource to explore the physiology of this key
eating quality trait.
Identification of gene pathways/networks whose ex-
pression is altered in response to nutritional modulation
would provide insight into the physiological/biochemical
processes important for muscle development and help to
uncover the mechanisms involved in IMF deposition in
porcine muscle [15,17]. The Duroc breed is characterised
by moderate levels of IMF [18] which is more easily ma-
nipulated compared to other commercial breeds and it
has been identified as a useful model for understanding
the physiological basis for muscle lipid metabolism [19].
Within a carcass there are a number of muscles which
exhibit favourable quality characteristics and command
relatively high value. The Musculus semimembranosus
(SM) is one such muscle that is particularly relevant to
ham production. Hence, the objective of this study was
to compare the phenotypic and transcriptomic response
between Duroc pigs maintained on low and high protein
diets during the finisher phase.
Results and discussion
Phenotypic response to dietary protein restriction
Although intakes did not differ significantly between ani-
mals on the low protein (LP) and high protein (HP) diets,
average daily gain and feed conversion ratio were signifi-
cantly lower in the animals on the LP diet (P < 0.001)
(Table 1). While carcass weight did not differ significantly
at slaughter, there was a tendency towards reduced carcass
weight in animals on the LP diet (P < 0.1). Muscle depthdid not differ between dietary treatments. However, fat
depth measured between the 3rd and 4th rib was greater
(P = 0.032) following the LP diet (Table 1). Composition
analysis indicated that there was no effect of treatment on
protein or moisture content in the muscle (P > 0.05). The
LP and HP diets did, however, have a significant effect on
fat content in the muscle: SM muscle derived from animals
on the LP diet had almost twice as much IMF (Table 1) as
muscle from the HP diet (3.60 ± 0.38% versus 1.92 ± 0.35%,
P < 0.001). Our results concur with those of D’Souza et al.
[20] and Bidner et al. [21] who also found a negative
relationship with growth, as well as a positive increment
in IMF deposition following protein restriction during
growth. The two levels of IMF generated lie each side of
the 2% IMF threshold for ‘desirable eating quality’ as sug-
gested by Devol et al. [6] and thus provide a useful model
for exploration of the molecular basis of eating quality.
Identification and functional characterisation of
differentially expressed genes in SM muscle associated
with dietary protein restriction
A total of 744 transcripts were differentially expressed
(DE) at the 0.05 level (P-like values from puma). Of these,
542 genes were annotated by ANEXdb [22] and are
presented in Additional file 1: Table S1. Fold changes
ranged from −6.29 to 5.14 and 130 genes had a greater
than 1.5 fold change across phenotypes. Previous studies
of gene expression in relation to meat quality have shown
that expression changes can be small [8,23] so in this
study, all transcripts with a cut off P-like value of P ≤ 0.05
were considered DE. Differential expression assessed by
realtime quantitative PCR (qPCR) for 13 selected genes
was in a similar direction and magnitude compared to
the microarray (Table 2). Although fold changes were
generally low, a number of functional modules were al-
tered and several broad patterns emerged through the
Table 2 Genes selected for realtime quantitative PCR (qPCR) validation of differential expression observed on the
microarray
Gene category Annotation
probe ID
Gene
symbol
Function Microarray qPCR
FC*# P-value FC*# P-value
Differentially expressed genes Ssc.27307.1.S1_at MPHOSPH6 Protein binding, RNA degradation 1.208 0.0009 1.413 0.006
Ssc.24599.1.S1_at UBE2CBP Ligase activity 1.179 0.010 1.293 0.005
Ssc.9340.1.A1_at LTBR Apoptosis 2.178 0.018 1.908 0.031
Ssc.16159.1.S1_at SCD Synthesis of unsaturated fatty acids 2.374 0.011 6.2 0.066
Ssc.17286.1.A1_at BTG2 Protein binding 1.763 0.012 2.418 0.015
Ssc.28320.1.S1_at CBX5 Chromatin binding, enzyme binding 1.357 5.86E-07 1.214 0.091
Ssc.17345.1.S1_at ANGPTL4 Enzyme inhibitor activity, receptor binding −2.204 7.3133E-06 −2.355 0.003
Ssc.3020.1.A1_at IQGAP2 Actin binding, cytoskeleton −1.415 1.6622E-05 −1.358 0.098
Ssc.26308.1.S1_at PROCR-like Receptor activity −1.991 0.001 −2.461 0.013
Ssc.27508.1.A1_at SATB2 Protein coding, transcription factor −1.409 7.1385E-05 −1.358 0.10
Non-changing genes Ssc.11026.1.S1_at RAP1 Cell adhesion and cell junction formation 1.000 0.98 1.267 0.16
Ssc.14406.1.A1_at MRPS6 Encodes ribosomal protein 1.001 0.96 1.241 0.22
Ssc.1480.1.S1_at PSMD1 Substrate recognition and binding 1.002 0.90 1.286 0.15
*FC: Fold change.
#Positive fold changes indicate that the low protein (LP) diet resulted in higher expression than the high protein (HP) diet and the number represents [expression
LP/ expression HP]. Negative fold changes indicate that the LP diet resulted in lower expression than the HP diet and the number represents {−[expression HP /
expression LP]}.
Gene expression changes (fold changes) and P-values determined by microarray and qPCR are shown.
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significant molecular and cellular functions, along with
the number of up- and down-regulated genes observed
in each function, are presented in Figure 1. The pathways
significantly over-represented in the DE genes are
presented in Table 3 and the most significant gene inter-
action network is presented in Figure 2, suggesting po-
tential specific mechanisms underlying the broader
biological functions. Taken together, these analyses sug-
gest that an array of cellular processes including cell div-
ision and growth, protein metabolism, lipid metabolism,
and the stress response were modulated in SM muscle by
dietary protein restriction. Almost twice as many tran-
scripts (351) were down-regulated, compared to up-
regulated (191) indicating a repression of transcription in
the SM muscle in response to protein restriction. Up-
and down-regulated gene-lists were analysed separately
using DAVID functional annotation clustering, permit-
ting evaluation of the high-level trends among the DE
genes, while reflecting the fact that genes have more than
one function or may be members of several pathways.
For up-regulated genes, three significant annotation clus-
ters (AC) were identified which cluster terms relating to
cell division, glucose metabolism and lipid metabolism,
respectively (Table 4). Four AC were identified for the
down-regulated gene-list (Table 5) with the first three of
these all grouping terms related to cell division and cell
cycle functions, while the fourth cluster represented
terms related to extracellular matrix and connective tissuedevelopment. The major patterns observed in the overall
dataset are discussed individually below.
Repression of cell cycle, cellular growth and tissue
development
In response to the lack of available protein in the diet,
animals on the LP diet appear to have had a reduced
capacity for efficient growth (Table 1). Functional anno-
tation of the DE genes highlighted a number of bio-
logical processes and those with the largest number of
down-regulated genes were ‘cellular growth and prolifer-
ation’, ‘tissue development’, ‘cell cycle’, ‘organismal develop-
ment’ and ‘skeletal and muscular system development’
(data from IPA). Of the observed genes which have func-
tions in growth and development, greater numbers were
down-regulated in tissue of animals on the LP diet than
were up-regulated (Figure 1), suggesting these are the
molecular mechanisms actively repressing growth in
this model. They included groups of genes with import-
ant functions such as ‘cellular assembly and organisation’
(30 genes down-regulated; 12 up-regulated), ‘cellular
growth and proliferation’ (79 down-regulated genes; 25
up-regulated) and ‘cell cycle’ (36 genes down-regulated;
20 up-regulated). IPA analysis (Table 3) revealed that
key growth-related pathways modulated by the protein-
restricted diet included, ‘alanine and aspartate metabolism’,
‘TGF beta signalling’, ‘Arachidonic acid metabolism’
pathway ‘nitrogen metabolism’, and ‘MAPK signal-
ling’, suggesting an overall repression of growth and
Figure 1 IPA molecular and cellular functions significantly over-represented among differentially expressed genes. *bars indicate the
likelihood [−log (P-value)] that the specific molecular and cellular function category was affected by the LP diet compared with the HP diet. The
number of up- and down-regulated genes in each group is represented on the right hand side. The cut-off is shown at P < 0.05 (1.301 log scale).
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the LP diet, which is reflected in the reduced average
daily gain and the tendency towards reduced carcass
weight (Table 1). Functional annotation clustering of
gene ontology term annotations in DAVID of down-
regulated (n = 351) genes showed that many of the
functional categories down-regulated in high IMF tissue
relate to reduced availability of protein in the muscle,
with significant categories such as ‘skeletal system devel-
opment’ and ‘morphogenesis’ indicating that these pro-
cesses may be repressed in a restricted protein regime
(Table 5). Three of the ACs related to cell division, cell
cycle and reflected the divergence of resource allocation
from protein deposition and growth. Despite the down-
regulation of numerous protein synthesis and cellular
growth pathways, there was no significant discrepancy inmuscle depth or muscle protein concentration at slaugh-
ter between the two dietary conditions (Table 1).
Several of the observed pathways differentially expressed
in muscle tissue, offer potential mechanisms, through
which the restriction of dietary protein may act to mediate
this inhibition of growth. The key difference between the
two diets was the availability of dietary protein, which
was energetically compensated for through inclusion of
carbohydrate. A key indicator pathway of amino acid
deprivation, ‘alanine and aspartate metabolism’, was
significantly over-represented in the data (Table 3).
For example, the asparagine synthetase gene, ASNS was
significantly induced in LP diet muscle. ASNS responds
to the deprivation of a wide range of different amino
acids, therefore suggesting that this signal may be in-
duced following amino acid restriction (Desvergne et al.
Table 3 Gene classification according to canonical signalling pathways* using IPA
Ingenuity® Canonical Pathways P-value % DE# Genes
Factors Promoting Cardiogenesis in Vertebrates 0.0021 8.51 TGFBR2, CCNE1, TGFB2, LEF1, TCF7L1, APC, PRKD1, CDK2
Antiproliferative Role of TOB in T Cell Signalling 0.0047 15.4 TGFBR2, CCNE1,TGFB2, CDK2
Alanine and Aspartate Metabolism 0.0061 5.68 ADSL, ASNSD1, DARS, MYO5B, ASNS
HIF1α Signalling 0.0066 7.27 MAPK8, MRAS, KRAS, MMP2, HIF1A, MMP24, NOS2, P4HTM
Nicotinate and Nicotinamide Metabolism 0.018 5.15 NT5C3, DAPK1, ENPP1, NEK2, MAPK8, MAK, CDK2
Apoptosis Signalling 0.025 6.67 CAPNS1, MAPK8, MRAS, KRAS, MAP4K4, PARP1
PPARα/RXRα Activation 0.031 5 TGFBR2, GPD1, MAPK8, MRAS, TGFB2, KRAS, MAP4K4, CYP2C19, ITGB5
Arachidonic Acid Metabolism 0.037 3.57 PLA2G4A, GPX3, CYP4B1, GPX5, ALOX12, CYP2C19, GPX6, PLOD3
Nitrogen Metabolism 0.039 3.01 CA9, CA3, ASNSD1, ASNS
Prolactin Signalling 0.039 6.49 SOCS3, SP1, MRAS, KRAS, PRKD1
p38 MAPK Signalling 0.043 6.25 TGFBR2, PLA2G4A, DDIT3, TGFB2, CREB3L4, HMGN1
ATM Signalling 0.047 7.55 CCNB1, MAPK8, CREB3L4, CDK2
NF-κB Activation by Viruses 0.048 6.00 CR2, ITGB5, KRAS, MRAS, PRKD1
Intrinsic Prothrombin Activation Pathway 0.049 8.60 COL3A1, COL5A3, PROS1
HGF Signalling 0.049 5.71 MAPK8, MRAS, KRAS, MAP3K3, PRKD1, CDK2
TGF-β Signalling 0.054 6.00 KRAS, MAPK8, MRAS, TGFB2, TGFBR2
#% DE: Percentage of genes annotated in that pathway that were observed differentially expressed in the present study.
*Cancer, disease-specific pathways, neurotransmitter and other nervous system signalling and pathogen-influenced signalling were excluded from the analysis.
Down-regulated genes are highlighted in bold, up-regulated genes are in normal typeface.
Hamill et al. BMC Genomics 2013, 14:453 Page 5 of 14
http://www.biomedcentral.com/1471-2164/14/4532006). This gene was also observed differentially expressed
between lean and fatter pig breeds, i.e. Large White versus
Basque [24]. A second significant pathway identified was
the ‘transforming growth factor-beta (TGF-β) signalling’
pathway. The ‘TGF-β signalling pathway’ was differentially
expressed and TGFBR itself was down-regulated (Table 3).
TGF-β plays key roles in regulating many cellular processes
such as cell growth and differentiation, homeostasis, apop-
tosis, inflammation [25,26] and extracellular matrix (ECM)
metabolism [27]. The ‘Arachidonic acid metabolism’ path-
way (Table 3) was also significantly modulated in the study.
Arachidonic acid is involved in cellular signalling and is
abundant in skeletal muscle [28]. Through its conversion
to active components such as the prostaglandin PGF2α,
arachidonic acid is necessary for the repair and growth of
skeletal muscle tissue and in general muscle anabolic pro-
cesses [29]. In the present study, the arachidonic acid path-
way was also generally down-regulated in response to
protein restriction (Table 3). Indeed, the second most re-
pressed gene in the experiment with a −3.254 fold change
was involved in arachidonic acid signalling i.e. potassium
voltage-gated channel, Shal-related subfamily, member 2
(KCND2) [30]. Ramayo-Caldas et al. [31] also observed
that the arachidonic acid pathway, including genes iden-
tified in the present study, such as CYP2C19, was sig-
nificantly differentially expressed in liver of Iberian X
Landrace pigs divergent for fatty acid content, suggesting
this pathway may also be an influence on accumulation
of fatty acids.Since the protein and amino acid composition of the
diet was extremely limiting (7 g/kg feed), in addition to
the reduced availability of protein for growth, there may
have been a reduced need for energy to excrete excess
protein, as suggested by the down regulation of genes in
the ‘nitrogen metabolism’ pathway (Table 3). Further-
more, myofibrillar protein turnover may also have been
restricted in high IMF tissue with observed down-
regulation of the CAPNS1 (Calpain small subunit 1)
gene. The repression of protein turnover could con-
tribute to the conservation and efficient utilisation of
a reduced resource of dietary protein. The efficient re-
sponse to dietary protein restriction may thus involve a
suppression of both protein synthesis and breakdown
pathways in order to achieve an overall improvement in
the efficiency of protein accretion in the myofibrils.
Extracellular matrix and connective tissue development
Connective tissue provides a source of physical strength
and scaffolding support for growing muscle tissue [32,33].
In the present study, procollagen genes COL3A1 (collagen,
type III, alpha 1) and COL5A3 (collagen type V, alpha 1)
were prominent in the most significant network (Figure 2)
and along with several other collagens (COL8A1 and the
only collagen strictly localised in the basement membrane
COL4A1) were reduced in expression in high IMF tissue.
Down-regulation of other genes important for collagen de-
velopment e.g. PLOD3 (pro-collagen-lysine, 2 oxoglutarate
5-dioxygenase 3), which codes for lysl hydroxylase and
Figure 2 Network 1: Molecular transport, lipid metabolism, small molecule biochemistry. Molecules are represented as nodes, and the
biological relationship between two nodes is represented as an edge (line). Up-regulated genes are indicated in red and down-regulated genes
are indicated in green.
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(arachidonate 12-lipoxygenase) was also seen in muscle
of animals on the LP diet (Table 3). While the extracellu-
lar matrix was long considered a relatively inert ground
substance, recent work has shown that it is an integral
component of cellular signalling, through the interaction
of extracellular matrix molecules with growth factors to
influence cell shape, movement and gene expression [35].
For example, studies have shown that the removal of col-
lagen VI stimulates the metabolism and survival of adipo-
cytes [36]. Functional annotation clustering (Table 5)
revealed that functions such as ‘extracellular matrix or-
ganisation’ and ‘extracellular structure organisation’ were
represented in AC 4 amongst the down-regulated genes
(e.g. COL3A1, COL5A3, NID1, DCN, ITGB5 etc.). Damon
and colleagues [24] investigated the Longissimus muscle
transcriptome of two breeds contrasting for fatness, thehighly selected Large White and the traditional unse-
lected Basque breed, which displays lower production
efficiency and higher IMF content compared to commer-
cial breeds. They identified extracellular matrix functions
as the most significantly over-represented group in their
dataset. They also observed some of the genes identified
in the present study such as decorin (DCN), which plays
an important role in matrix assembly and whose im-
paired expression has a major influence on the collagen
network. The extra-cellular matrix is an important influ-
ence underpinning differential cell and muscle tissue
modelling. Identification of this component as being dif-
ferentially expressed in two such contrasting animal
models (dietary restriction and breed comparison) con-
firms its biological importance in the determination of
composition and organisation of muscle tissue, as well as
its significance to regulation of IMF.
Table 4 Functional annotation clustering of up-regulated genes by DAVID
Annotation Cluster 1- Count P-value+ Genes
Enrichment Score: 1.33
GO:0000087 ~ M phase of mitotic cell cycle 8 0.008 SSSCA1, FZR1, DDX11, NEK3, DSN1, RAN, MPHOSPH6, APC
GO:0000280 ~ nuclear division 7 0.025 SSSCA1, FZR1, DDX11, NEK3, DSN1, RAN, APC
GO:0007067 ~mitosis 7 0.025 SSSCA1, FZR1, DDX11, NEK3, DSN1, RAN, APC
GO:0048285 ~ organelle fission 7 0.030 SSSCA1, FZR1, DDX11, NEK3, DSN1, RAN, APC
GO:0000278 ~mitotic cell cycle 9 0.036 SSSCA1, FZR1, PSMA6, DDX11, NEK3, DSN1, RAN, MPHOSPH6, APC
Annotation Cluster 2- Count P-value Genes
Enrichment Score: 1.26
GO:0010906 ~ regulation of glucose metabolic process 3 0.050 LEP, HIF1A, ECD
Annotation Cluster 3- Count P-value Genes
Enrichment Score: 1.15
GO:0019637 ~ organophosphate metabolic process 7 0.017 SERINC2, GPD1, PIGU, PIGB, GALT, FIG 4, LIPC
GO:0046486 ~ glycerolipid metabolic process 6 0.025 SERINC2, GPD1, PIGU, PIGB, FIG 4, LIPC
GO:0006650 ~ glycerophospholipid metabolic process 5 0.033 SERINC2, PIGU, PIGB, FIG 4, LIPC
+P-value from modified Fisher exact score.
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Finisher pigs on the LP diet were characterised by a redirec-
tion of energy from overall growth to fat deposition, with
increased fat accumulation in adipose depots including sub-
cutaneous fat and IMF content (Table 1). This concept is
supported by the observation that many of the up-
regulated processes in SM muscle from animals on the LP
diet have functions associated with increased lipid metabol-
ism, and in particular synthesis (Tables 2, 3, 4 and Figures 1
and 2). IPA analysis of biological processes indicated that
high IMF muscle displayed up-regulation of genes related
to ‘phospholipid metabolic process’, ‘glycerolipid biosynthetic
process’, ‘lipid biosynthetic process’, ‘organophosphate meta-
bolic process’, as well as ‘glucose metabolic process’,‘regulation
of cellular carbohydrate metabolic process’, ‘regulation of
carbohydrate metabolic process’ and ‘cell division’, ‘mitosis’,
‘mitotic cell cycle’. Key pathways modulated by the protein-
restricted diet include those involved with fatty acid uptake
(‘PPAR alpha/ RXR alpha’) and fatty acid synthesis
(‘glycerolipid metabolic process’ and ‘glycerophospholipid
metabolic process’).
Peroxisome proliferator activated receptor-alpha (PPARα)
is a ligand-activated transcription factor that belongs to the
nuclear receptor family. PPARα signalling plays major roles
in the stimulation of uptake, binding, activation and conse-
quent oxidation of fatty acids in several tissues including
skeletal muscle [37]. PPARα is highly expressed in a num-
ber of tissues (skeletal and heart muscle, liver, and brown
adipose tissue) with high levels of lipid catabolism and is ac-
tivated by polyunsaturated fatty acids [38-40]. Here, differ-
ential expression of 9 genes involved in ‘PPARα/RXRα
activation’ (Table 1) was observed and these genes were in
general up-regulated in the higher IMF condition. Canovaset al. [19] also observed induced PPARα signalling in
muscle of pigs with high levels of IMF content and this is
also reflected in liver of pigs divergent for fatty acid profile
[31]. PPARα signalling was also highlighted in pathways
relevant to carbohydrate metabolism indicating a high-level
modulation of energy-generating and consuming pathways
in muscle.
Network analysis and functional annotation of biological
processes (Figure 2 and Table 4) revealed over-expression
of a number of other genes with functions in lipid metabol-
ism, including membrane lipid biosynthesis (e.g. SERINC2,
LTBR, MLYCD, PIGU, FIG 4, GPD1 etc.), but which are not
well known in relation to IMF accumulation. SERINC2
(serine incorporator 2) is a member of the serine incorpor-
ator family which plays a pivotal role in the regulation of
lipid biosynthesis by facilitating the synthesis of the serine-
derived lipids, phosphatidylserine and sphingolipids [41].
Here, SERINC2 was highly up-regulated and was a member
of the top network. SERINC2 has not been well-studied in
the context of meat quality but was recently identified
within a QTL for fatty acid profile [42]. Phospholipases are
critical enzymes involved in mediating many aspects of
cellular function through modulating the physical proper-
ties of membranes, generation of lipid second messengers
and cellular bioenergetics. Cytosolic calcium-dependent
phospholipase A2, group IVA (PLA2G4A) has been shown
to mediate the increase in triglyceride content of adipose
tissue after high-fat feeding [43] and here it was down-
regulated in high IMF tissue. Lymphotoxin β Receptor
(LTBR) is a member of the tumor necrosis factor receptor
superfamily and has been shown to be an important medi-
ator of lipid homeostasis [44]. Malonyl CoA decarboxylase
(MLYCD) acts to increase the rate of fatty acid oxidation
Table 5 Functional annotation clustering of down-regulated genes by DAVID
Annotation Cluster 1- Count P-value+ Genes
Enrichment Score: 2.63
GO:0051301 ~ cell division 18 3.317E-05 KIAA0892, NEK2, NUSAP1, CECR2, BIRC5, RACGAP1, MCM5, CDK2,
SMC4, CCNB1, CCNE1, MAD2L1, NSL1, CKS2, BUB1, CHFR, ASPM,
SPAST
GO:0000280 ~ nuclear division 13 0.0008 KIAA0892, NEK2, NUSAP1, AURKA, BIRC5, CDK2, SMC4, CCNB1,
MAD2L1, NSL1, BUB1, CHFR, ASPM
GO:0007067 ~mitosis 13 0.0008 KIAA0892, NEK2, NUSAP1, AURKA, BIRC5, CDK2, SMC4, CCNB1,
MAD2L1, NSL1, BUB1, CHFR, ASPM
GO:0000087 ~ M phase of mitotic cell cycle 13 0.0009 KIAA0892, NEK2, NUSAP1, AURKA, BIRC5, CDK2, SMC4, CCNB1,
MAD2L1, NSL1, BUB1, CHFR, ASPM
GO:0048285 ~ organelle fission 13 0.001 KIAA0892, NEK2, NUSAP1, AURKA, BIRC5, CDK2, SMC4, CCNB1,
MAD2L1, NSL1, BUB1, CHFR, ASPM
GO:0000279 ~ M phase 16 0.001 KIAA0892, NEK2, NUSAP1, AURKA, BIRC5, PIM2, CDK2, SMC4, RPA1,
CCNB1, MAD2L1, NSL1, CKS2, BUB1, CHFR, ASPM
GO:0007049 ~ cell cycle 27 0.002 CLSPN, NEK2, AURKA, SESN1, RPA1, CCNE1, BUB1, ASPM, KIAA0892,
NUSAP1, BIRC5, PIM2, GAS1, RACGAP1, CDK2, SMC4, CCNB1,
MAD2L1, NSL1, RASSF2, CKS2, G0S2, SIAH2, CHFR, CCNDBP1,
SPAST, TP53INP1
GO:0007059 ~ chromosome segregation 7 0.004 KIAA0892, MAD2L1, NEK2, NSL1, NUSAP1, BIRC5, SMC4
GO:0022402 ~ cell cycle process 21 0.004 KIAA0892, NEK2, NUSAP1, AURKA, BIRC5, PIM2, GAS1, RACGAP1,
SESN1, CDK2, SMC4, RPA1, CCNB1, CCNE1, MAD2L1, NSL1, CKS2,
BUB1, CHFR, ASPM, TP53INP1
GO:0000070 ~mitotic sister chromatid segregation 5 0.004 KIAA0892, MAD2L1, NEK2, NUSAP1, SMC4
GO:0022403 ~ cell cycle phase 17 0.004 KIAA0892, NEK2, NUSAP1, AURKA, BIRC5, PIM2, CDK2, SMC4, RPA1,
CCNB1, CCNE1, MAD2L1, NSL1, CKS2, BUB1, CHFR, ASPM
GO:0000819 ~ sister chromatid segregation 5 0.005 KIAA0892, MAD2L1, NEK2, NUSAP1, SMC4
GO:0007346 ~ regulation of mitotic cell cycle 9 0.007 MAD2L1, HOXA13, NEK2, BUB1, NUSAP1, BIRC5, GAS1, CHFR, CDK2
GO:0000278 ~mitotic cell cycle 14 0.020 KIAA0892, NEK2, NUSAP1, AURKA, BIRC5, CDK2, SMC4, CCNB1,
CCNE1, MAD2L1, NSL1, BUB1, CHFR, ASPM
GO:0051726 ~ regulation of cell cycle 12 0.043 CCNB1, MAD2L1, HOXA13, TBX3, NEK2, BUB1, CKS2, NUSAP1,
BIRC5, GAS1, CHFR, CDK2
Annotation Cluster
2- Enrichment Score: 1.66
Count P-value Genes
GO:0007346 ~ regulation of mitotic cell cycle 9 0.007 MAD2L1, HOXA13, NEK2, BUB1, NUSAP1, BIRC5, GAS1, CHFR, CDK2
GO:0010564 ~ regulation of cell cycle process 7 0.019 MAD2L1, HOXA13, NEK2, BUB1, NUSAP1, BIRC5, GAS1
GO:0007088 ~ regulation of mitosis 5 0.019 MAD2L1, HOXA13, NEK2, BUB1, NUSAP1
GO:0051783 ~ regulation of nuclear division 5 0.019 MAD2L1, HOXA13, NEK2, BUB1, NUSAP1
GO:0051726 ~ regulation of cell cycle 12 0.043 CCNB1, MAD2L1, HOXA13, TBX3, NEK2, BUB1, CKS2, NUSAP1,
BIRC5, GAS1, CHFR, CDK2
GO:0033043 ~ regulation of organelle organization 9 0.048 CAV1, PLA2G4A, MAD2L1, HOXA13, NEK2, ELN, BUB1, NUSAP1, TMSB10
Annotation Cluster
3- Enrichment Score: 1.35
Count P-value Genes
GO:0010564 ~ regulation of cell cycle process 7 0.019 MAD2L1, HOXA13, NEK2, BUB1, NUSAP1, BIRC5, GAS1
GO:0031577 ~ spindle checkpoint 3 0.020 MAD2L1, BUB1, BIRC5
Annotation Cluster
4- Enrichment Score: 1.33
Count P-value Genes
GO:0043062 ~ extracellular structure organization 9 0.011 GJA10, NRXN3, FBLN5, ELN, COL3A1, NID1, DCN, COL5A3, GFOD2
GO:0030198 ~ extracellular matrix organization 7 0.012 FBLN5, ELN, COL3A1, NID1, DCN, COL5A3, GFOD2
GO:0007160 ~ cell-matrix adhesion 6 0.024 LYVE1, FBLN5, COL3A1, ITGB5, NID1, COL5A3
GO:0031589 ~ cell-substrate adhesion 6 0.035 LYVE1, FBLN5, COL3A1, ITGB5, NID1, COL5A3
+P-value from modified Fisher exact score.
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cating that not only is lipid biosynthesis and accumulation
up-regulated but that fatty acid turnover may be repressed.
Stearoyl CoA Desaturase (SCD) is the catalyst of the con-
version of saturated fatty acids to monounsaturated fatty
acids (MUFA) [45,46] and is of interest from a health per-
spective and was highly up-regulated in the LP diet,
confirming its association with IMF accumulation which is
in accordance with observations by Canovas et. al [47] and
da Costa et al. [15]. These genes are potential markers of
fatty acid uptake, binding, storage and oxidation.
As well as its roles in cell growth and differentiation,
expression of the TGF-β signalling pathway suppresses pre-
adipoctye differentiation and reduces expression of glycerol-
3-phosphate dehydrogenase (GPD1) [48]. The observed
repression of the TGF-β signalling pathway and increased
expression of GPD1 in muscles of animals on the LP diet is
thus a candidate mechanism for the increased orientation
towards adipocyte differentiation and proliferation and may
stimulate the accumulation of IMF in this model.
While the primary function of adipocytes are to store
triacylglycerols during periods of energetic excess and re-
lease again during periods where energy is deprived, adipo-
cytes are also a major source of endocrine and paracrine
signals [1]. Adipogenic endocrine factors and secretory
products are important mediators of energy homeostasis,
immunological response, vascular disease and appetite
regulation. ANGPTL4 (known as fasting-induced adipo-
cyte factor), the hepatic fibrinogen/angiopoietin-related
protein, or PPAR-γ angiopoietin-related protein, is a se-
creted glycoprotein abundantly expressed in adipocytes
[49]. ANGPTL4 abundance may be an indicator of IMF ac-
cumulation in porcine muscle. Network 1 (with functions
in ‘molecular transport’, ‘lipid metabolism’, ‘small molecule
biochemistry’) may be seen in Figure 2 and included 19
down-regulated and 7 up-regulated genes. Leptin (LEP)
was a hub molecule in this network and was up-regulated
and a number of its downstream genes were also altered
(e.g. ACSL1, MAP3K3, MAPK8, PNPLA3). Leptin is se-
creted from adipose cells and acts as “lipostat” regulating
food intake and energy expenditure to maintain body
weight homeostasis [50,51]. Indeed, several studies have
shown that high circulating levels of leptin inhibit fatty acid
esterification in rodent [52] and porcine skeletal muscle
[53] and promote lipid oxidation. Higher expression of
LEP is expected when a greater number of adipocytes are
present and when fat content of adipocytes is higher
[49,54,55]. Our study supports the observed associations of
LEP with high IMF accumulation in muscle tissue in line
with previous findings [19].
Induction of hypoxic stress response
Seven genes in the ‘HIF1α signalling’ cascade were up-
regulated (P = 0.006). Hypoxia-Inducible Factor (HIF1) isa transcription factor that regulates the homeostatic re-
sponses to hypoxia by inducing expression of proteins
controlling glucose metabolism, cell proliferation, and
angiogenesis [56]. The relatively larger expanse of adi-
pose tissue in high IMF muscle, as is present in LP ani-
mals leads to the formation of hypoxic areas, as some
adipocytes become too distant from the vasculature to
receive oxygen properly [56,57]. HIF1-α expression has
also been proposed elsewhere as a marker of IMF accu-
mulation in pigs naturally divergent in IMF content [8].
Apoptosis in adipocytes can be induced through cell sig-
nalling in response to hypoxia, via the insulin-signalling
pathway, leading to inhibition of glucose uptake and re-
lease of free fatty acids [58] and here the ‘apoptosis sig-
nalling’ cascade was also significantly represented among
the DE genes.
Mechanisms regulating IMF accumulation in response to
dietary protein restriction and other experimental models
Two previous studies have examined the influence of re-
striction of protein in porcine diet on gene expression
and phenotype in porcine muscle. Da Costa et al. [15]
examined energy and protein restriction and applied a
small muscle specific microarray to male Duroc pigs on
restricted and adequate energy and protein. Oster et al.
[59] applied a reduced protein supply to the maternal
diet during gestation; subsequently measuring phenotype
and transcription in the offspring at different stages post
mortem using the same array platform as employed in
the present study. Da Costa et al. [15] in common with
the present study, found reduced growth performance
and increased IMF accumulation in pigs on restricted
protein and energy diets. While in the present study, we
have only studied one muscle, similarities were observed
in the pathways and functions modulated across all three
studies, and a number of pathways, e.g. fatty acid metab-
olism, were commonly differentially expressed in all
three studies. Our phenotypic and gene expression find-
ings in relation to dietary restriction at the post natal
stage show interesting parallels with the impact of re-
stricted protein at the gestational stage [59]. Restriction
of growth performance was observed in the pigs re-
stricted in protein during gestation as in those of the
present study, which were restricted in protein in their
own diets. Offspring offered poor protein supply during
gestation had significantly lower body weight and lowered
transcriptional abundance of growth-related genes and
pathways at day 1 post natal. They compensated in
terms of weight when offered adequate protein in later
growth stages, but this was driven by fat accumulation
while myofibrillar numbers remained low [59]. Despite
reduced lean growth performance it was noteworthy
however that major transcriptional differences as a result
of protein restriction in gestation were not evident until
Table 6 Composition and chemical analysis of LP
(12.8% protein) and HP (21.7% protein) diets
LP diet HP diet
Ingredient (g/Kg)
Barley 200 200
Wheat 643 399.3
Soya bean meal 86 341
Tallow 42 34.2
Dical phosphate 10 6.2
Limestone 9.6 10.8
Salt 5 5
Lysine-HCL 2 1
Mineral and vitamins 2.5 2.5
Total 1000.0 1000
Analysed Composition (g/Kg)
Dry Matter 885.0 890.0
Crude Protein (N x 6.25) 128.0 217.0
Ash 39.3 37.3
Crude Fibre 33.3 41.3
Crude Oil 25.1 34.3
Gross Energy (MJ) 15.7 15.8
Lysine 7.0 13.0
Methionine + Cysteine 4.2 7.8
Threonine 4.6 8.5
Tryptophan 1.3 2.3
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ways such as ‘oxidative phosphorylation’, ‘fatty acid me-
tabolism’, ‘cell cycle regulation’ and ‘citrate cycle’ were
differentially expressed in both model systems. This indi-
cates that the major transcriptional shifts we have ob-
served in the present study by restriction of protein in
later stages of growth are also entailed by restriction of
protein at the gestational stage. While dietary protein re-
striction is just one strategy to modify IMF content, a
comparison of these studies and the study of Damon
et al. [24], which applies a different model of differential
IMF content, i.e. studying breeds contrasting for fatness,
indicates that common metabolic processes may be in-
duced by diverse stimuli such as genetics, nutrition and
fetal programming. These common mechanisms lead to
major differences in phenotypic outcomes for muscle tis-
sue structure and organisation and give rise to important
consequences for meat nutritional and eating quality.
Conclusions
In this study, two extremes of IMF content were success-
fully generated using dietary lysine protein restriction. Re-
markable differences were evident in the transcriptomic
profiles. For example, LP muscle displayed over-expression
of genes related to lipogenesis and lipolysis, while several
genes known to be associated with adipoctye mass such
as SCD and LEP were up-regulated. Functional categories
which were decreased in their expression related to
growth and development, protein synthesis and extracel-
lular matrix development and organisation. The major
patterns revealed by bioinformatic functional annotation
clustering therefore involve restriction of cellular and
muscle growth, cellular remodelling and differential ex-
pression of numerous lipid metabolic processes. A low
protein diet can modulate IMF content by altering gene
pathways involved in lipid biosynthesis and degradation;
however this nutritional challenge negatively impacts pro-
tein synthesis pathways, which may have potential conse-
quences for overall growth. The involvement of key master
regulators of energy homeostasis illustrates the extensive
perturbation of overall energy metabolism in muscle that
occurs in response to protein restriction. Furthermore, the
high IMF condition in this nutritional model is associated
with a suite of responses which have also been observed in
genetic and fetal programming models and thus may pro-
vide robust biological indicators of IMF accumulation.
Methods
Animals and treatments
All procedures described in this experiment were
conducted under experimental licence from the Irish
Department of Health in accordance with the Cruelty to
Animals Act 1876 and the European Communities
(Amendments of the cruelty of Animals Act 1976)Regulations, 1994. Eleven purebred Duroc gilts were
blocked on the basis of initial body weight (BW) (46.3 ±
4.2 kg) and assigned to one of two dietary treatments.
High (HP) and low protein (LP) diets were formulated to
contain 217 and 128 g/kg crude protein (CP) respectively.
Diet composition and nutrient analysis are detailed in
Table 6. The HP and LP diets contained 13.0 and 7 g/kg
of total lysine, respectively. Downward adjustment of CP
was achieved by increasing the wheat:soyabean meal ra-
tio. Diets were isocaloric, formulated to an estimated di-
gestible energy (DE) density of 14 MJ/kg. Through the
addition of synthetic amino acids, the dietary concentra-
tions of threonine, tryptophan and total sulphur-
containing amino acids were maintained at 65, 20 and
60% of lysine, respectively, which was sufficient to satisfy the
ideal protein requirement [60]. The diets were manufactured
into 3 mm pellets after heating the food to 85°C. Analysis of
diets for dry matter (DM) and ash was carried out according
to Association of Analytical Chemists (1995). Samples of
feed were analysed for ether extract according to the Soxhlet
method, using a Soxtec System (model 1043, Tecator,
Sweden). The gross energy (GE) of feed and faeces samples
was measured using an adiabatic bomb calorimeter (Parr In-
struments, Il, USA). Dietary crude fibre was analysed by the
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tractor (Tecator, Sweden). The dietary concentration of ly-
sine, threonine, tryptophan and total sulphur amino acids
was determined by high performance liquid chromatography
[62]. The crude protein (CP, N x 6.25) concentration of feed
was analysed by the macro-Kjeldahl technique using a Buchii
distillation apparatus.
At approximately 10 weeks of age, six gilts were allocated
to the HP diet and five gilts were allocated to the LP diet
for 63 days. The pigs were penned in two groups with a
space allowance of 0.75 m2 per pig. The house was mech-
anically ventilated to provide an ambient temperature of
18°C. Each pen had a solid floor lying area with access to
slats. The pigs had ad libitum access to the diets. The pens
were equipped with single-space computerized feeders
(Mastleistungsprufung MLP-RAP; Schauer Agrotronic AG,
Sursee, Switzerland) as described previously by Pauly et al.
[63]. The pigs were weighed at the start of the experiment
and subsequently on days 28 and 63 (morning of slaughter)
and feed intake was recorded daily.
On day 63 of the experiment, animals were transported to
the pilot-scale abattoir at Teagasc Food Research Centre,
Ashtown. M. semimembranosus (SM) tissue was removed
from each carcass, cut up finely under RNAse free condi-
tions and preserved in RNALater® (Ambion) within 10 min
post-slaughter, stored overnight at 4°C, and then stored at
−20°C until RNA extraction. At day 1 post-mortem, SM
muscle tissues were removed from the carcass, trimmed of
subcutaneous fat and archived at −20°C for downstream
compositional analysis.
Phenotype analysis
Fat and muscle depth were assessed on the carcass using
the Hennessy Grading Probe according to supplier’s
recommended protocol. Thawed muscle was cut into
3 cm3 cubes and homogenized using a Robot R301 Ultra
Coupe blender (Robot Coupe Inc., MS, USA). IMF and
moisture concentrations were determined using the
Smart System 5 microwave moisture drying oven and
NMR Smart Trac Rapid Fat Analyzer (CEM Corpor-
ation, Buckingham UK) using AOAC Official Methods
985.14 and 985.26, 1990. Protein concentration was de-
termined using a LECO FP328 (LECO Corp., MI, USA)
Protein Analyser based on the Dumas method and
according to AOAC method 992.15, 1990. The least
squares method of the GLM (General Linear Model)
procedure in SAS [64] was carried out for statistical
analysis of post-slaughter phenotypic and compositional
measurements. Diet, slaughter weight and slaughter
date were included in the model.
RNA extraction and cDNA synthesis
RNA extraction was carried out by Almac Diagnos-
tics, UK. Briefly, preserved SM tissue samples werehomogenised and processed using a standard phenol/
guanidine isothiocyanate-based organic extraction method
(e.g.TRI-Reagent, TRIZOL, or RNA STAT-60). RNA sam-
ples were analysed for concentration, purity and integrity
using spectrophotometric and gel-based methods. Only
samples with A260/280 ratios approximately 1.8-2.0 and
two distinct peaks (for the 18S and 28S bands) were used
to generate labelled targets.
For qPCR, one μg of DNAse-treated total RNA was
used for cDNA synthesis using random primers and
Superscript® III reverse transcriptase (Invitrogen Corp.,
San Diego, CA, USA). Negative control samples were
prepared to ensure no genomic DNA contamination
was present.
Microarray hybridisation
Gene expression profiling was performed using the
Affymetrix GeneChip® Porcine Genome Array containing
23,937 probe sets that interrogate approximately 23,256
porcine transcripts from 20,201 Sus scrofa (pig) genes.
RNA from each pig was hybridised to a separate array. Hy-
bridisation, processing and preliminary analysis of porcine
SM muscle RNA samples were carried out by Almac
Diagnostics, UK, according to the manufacturer’s instruc-
tions. Briefly, 100 ng of total RNA was amplified using the
NuGEN™ Ovation™ RNA Amplification System V2. After
obtaining the first double-stranded cDNA, the appropriate
amount of amplified single-stranded cDNA was used as a
template for biotin labelling using the FL-Ovation™ cDNA
Biotin Module V2. The enzymatically and chemically
fragmented product (50–100 bp) was then labelled via the
attachment of biotinylated nucleotides onto the 3′-end of
the fragmented cDNA. The resultant fragmented and la-
belled cDNA was added to the hybridisation mix in ac-
cordance with the NuGEN™ guidelines for hybridisation
onto Affymetrix GeneChip® arrays. Post hybridisation
washing and staining were carried out using GeneChip®
Fluidics Station 450 (Affymetrix) followed by scanning
according to standard Affymetrix protocols.
Data analysis and bioinformatics
Microarray analysis including, pre-processing, normal-
isation and statistical analysis were performed using R
(R, 2007) version 2.6 and Bioconductor [65] version 2.1.,
as previously described by Morris et al. [66]. Quality of
data was determined before and after normalisation
using a number of in-built QC methods as implemented
in the Bioconductor Affycoretools and integrated pack-
ages to visualise problems if any existed, following array
hybridisation, RNA degradation and data normalisation.
The Propagating Uncertainty in Microarray Analysis
(puma) method was used to estimate fold changes and
P-like values for differential gene expression [67-69].
The puma package permits the use of probe level
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pared to traditional methods of differential gene expres-
sion analysis, principal component analysis and
clustering. It uses a Bayesian hierarchical model to cal-
culate the probability of positive likelihood ratio (PPLR)
of differential gene expression. The PPLR associates
probability values of genes being differentially expressed,
which is a measure of the false positive detection of dif-
ferential expression, to each ratio and generates lists of
genes ranked by the probability of being DE. This PPLR
statistic was converted into P-like values using the
recommended formula in the puma method prior to
subsequent analysis. The data set, which is compliant to
the MIAME criteria, is deposited at Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/)
under the series accession number GSE44326.
Annotation and ontology analysis
ANEXdb (an integrated animal ANnotation and micro-
array EXpression database) [22] was used for annota-
tion of DE genes. Following annotation, gene symbols
were submitted to DAVID (Database for Annotation,
Visualization and Integrated Discovery [70,71] with the
purpose of determining gene function and to cluster genes
into functionally significant gene clusters and also to deter-
mine significant biological pathways through KEGG (Kyoto
Encyclopaedia of Genes and Genomes: [72,73]. Ingenuity
Pathway Analysis (IPA, version 8.7, Ingenuity® Systems,
CA, USA) was used for functional classification of DE
genes. IPA is web-based software that allows identification
of pathways, biological network and functions of experi-
mental data and gene lists. In order to identify pathways
that were more relevant to the metabolic processes of
interest, cancer, disease-specific, neurotransmitter, nervous
system signalling and pathogen-influenced signalling path-
ways were excluded from the IPA analysis.
Realtime quantitative PCR (qPCR) validation of selected
DE genes
Gene specific primers were designed online using the
Primer3 software (http://frodo.wi.mit.edu/primer3/) based
on the porcine target sequences used on the Affymetrix
array. All corresponding consensus expressed sequences
were derived using the NetAffx Analysis Centre (http://
www.affymetrix.com/analysis/index.affx) on the website.
Specificity of primers was determined using the BLAST
search tool on NCBI database (http://www.ncbi.nlm.nih.
gov/BLAST). Oligonucleotides were commercially synthe-
sised (Eurofins, Germany) and an initial conventional PCR
reaction confirmed for each target gene that all RNA sam-
ples were free of contaminating genomic DNA with one
distinct band present on a 1.2% agarose gel.
Primer sequences for three selected reference genes
Beta 2 microglobulin (β2M), TATA box binding protein(TBP) and Ribosomal protein L4 (RPL4) are described in
detail in McBryan et al. [74]. qPCR was performed on
96-well plates and reactions were carried out in triplicate
for each cDNA sample. One μl of cDNA was amplified
in a 20 μl volume using 10 μl SYBR® Green master mix
and 1 μl of 0.2 μM forward and reverse primer mix and
8 μl nuclease free water (QIAGEN Ltd., West Sussex,
UK). Cycling conditions for reference and selected genes
on the 7500 system (Applied Biosystems, Foster City,
CA, USA) were as follows: 50°C for 2 min, 95°C for
10 min, 40 cycles of 95°C for 15 s and 60°C for 1 min,
95°C for 15 s, 60°C for 1 min, 95°C for 15 s. All reactions
included a dissociation curve analysis at the end of the
amplification to confirm a single product at the expected
melting temperature. Relative expression values were de-
termined by comparison to a standard curve using serial
dilutions of a pool of cDNA. The relative stability of the
three reference genes was analysed using GeNorm [75].
Ten DE genes (six up-regulated: MPHOSPH6, UBE2CBP,
PNPLA3, SCD, BTG2, CBX5 and four down-regulated:
ANGPTL4, IQGAP2, PROCR, SATB2) were selected based
on their fold changes and their known functional
roles in lipid, amino acid or skeletal muscle metabolism.
In addition to these genes, three non-changing genes
(RAP1, MRPS6 and PSMD1) were also selected for the
confirmation of microarray analysis. The thirteen genes
(ten DE genes and three non-changing genes) with details
of accession number, gene symbol, primer sequences,
and product size are listed in Additional file 1: Table S2.
Additional file
Additional file 1: Table S1. 542 differentially expressed probesets and
associated annotations from Anexdb. Table S2. Primer details for
reference, differentially expressed and non-changing genes.
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